The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages (2022)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.956991
PubMed Identifier: 35967296
Publication URI: http://europepmc.org/abstract/MED/35967296
Type: Journal Article/Review
Parent Publication: Frontiers in Immunology
ISSN: 1664-3224